208 related articles for article (PubMed ID: 31776036)
1. Synthesis of d-ring modified acid hydrazide derivatives of podophyllotoxin and their anticancer studies as Tubulin inhibiting agents.
Nerella S; Kankala S; Paidakula S; Gavaji B
Bioorg Chem; 2020 Jan; 94():103384. PubMed ID: 31776036
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of podophyllotoxin congeners as tubulin polymerization inhibitors.
Kamal A; Srinivasa Reddy T; Polepalli S; Shalini N; Reddy VG; Subba Rao AV; Jain N; Shankaraiah N
Bioorg Med Chem; 2014 Oct; 22(19):5466-75. PubMed ID: 25131956
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, biological evaluation, and 3D-QSAR analysis of podophyllotoxin-dioxazole combination as tubulin targeting anticancer agents.
Wang ZZ; Sun WX; Wang X; Zhang YH; Qiu HY; Qi JL; Pang YJ; Lu GH; Wang XM; Yu FG; Yang YH
Chem Biol Drug Des; 2017 Aug; 90(2):236-243. PubMed ID: 28079286
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of piperazine acetate podophyllotoxin ester derivatives targeting tubulin depolymerization as new anticancer agents.
Sun WX; Ji YJ; Wan Y; Han HW; Lin HY; Lu GH; Qi JL; Wang XM; Yang YH
Bioorg Med Chem Lett; 2017 Sep; 27(17):4066-4074. PubMed ID: 28757065
[TBL] [Abstract][Full Text] [Related]
5. Investigation of podophyllotoxin esters as potential anticancer agents: synthesis, biological studies and tubulin inhibition properties.
Shareef MA; Duscharla D; Ramasatyaveni G; Dhoke NR; Das A; Ummanni R; Srivastava AK
Eur J Med Chem; 2015 Jan; 89():128-37. PubMed ID: 25462233
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of a series of podophyllotoxins derivatives as a class of potent antitubulin agents.
Liu Y; Wei D; Zhao Y; Cheng W; Lu Y; Ma Y; Li X; Han C; Wei Y; Cao H; Zhao C
Bioorg Med Chem; 2012 Nov; 20(21):6285-95. PubMed ID: 23022053
[TBL] [Abstract][Full Text] [Related]
7. Identification of new 3-phenyl-1H-indole-2-carbohydrazide derivatives and their structure-activity relationships as potent tubulin inhibitors and anticancer agents: A combined in silico, in vitro and synthetic study.
Saruengkhanphasit R; Butkinaree C; Ornnork N; Lirdprapamongkol K; Niwetmarin W; Svasti J; Ruchirawat S; Eurtivong C
Bioorg Chem; 2021 May; 110():104795. PubMed ID: 33730670
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of benzo[b]furo[3,4-e][1,4]diazepin-1-one derivatives as anti-cancer agents.
Malayeri SO; Tayarani-Najaran Z; Behbahani FS; Rashidi R; Delpazir S; Ghodsi R
Bioorg Chem; 2018 Oct; 80():631-638. PubMed ID: 30041139
[TBL] [Abstract][Full Text] [Related]
9. Design and Synthesis of Novel Podophyllotoxins Hybrids and the Effects of Different Functional Groups on Cytotoxicity.
Yang Z; Zhou Z; Luo X; Luo X; Luo H; Luo L; Yang W
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011453
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of podophyllotoxin derivatives as selective antitumor agents.
Wu GR; Xu B; Yang YQ; Zhang XY; Fang K; Ma T; Wang H; Xue NN; Chen M; Guo WB; Jia XH; Wang PL; Lei HM
Eur J Med Chem; 2018 Jul; 155():183-196. PubMed ID: 29886322
[TBL] [Abstract][Full Text] [Related]
11. Novel Podophyllotoxin Derivatives as Potential Tubulin Inhibitors: Design, Synthesis, and Antiproliferative Activity Evaluation.
Han HW; Lin HY; He DL; Ren Y; Sun WX; Liang L; Du MH; Li DC; Chu YC; Yang MK; Wang XM; Yang YH
Chem Biodivers; 2018 Nov; 15(11):e1800289. PubMed ID: 30194898
[TBL] [Abstract][Full Text] [Related]
12. One-pot synthesis and biological evaluation of N-(aminosulfonyl)-4-podophyllotoxin carbamates as potential anticancer agents.
Xu XH; Guan XW; Feng SL; Ma YZ; Chen SW; Hui L
Bioorg Med Chem Lett; 2017 Jul; 27(13):2890-2894. PubMed ID: 28512026
[TBL] [Abstract][Full Text] [Related]
13. 4β-[(4-Alkyl)-1,2,3-triazol-1-yl] podophyllotoxins as anticancer compounds: design, synthesis and biological evaluation.
Reddy DM; Srinivas J; Chashoo G; Saxena AK; Sampath Kumar HM
Eur J Med Chem; 2011 Jun; 46(6):1983-91. PubMed ID: 21477899
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxins as potential anticancer agents.
Reddy PB; Agrawal SK; Singh S; Bhat BA; Saxena AK; Kumar HM; Qazi GN
Chem Biodivers; 2008 Sep; 5(9):1792-802. PubMed ID: 18816530
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of podophyllotoxin linked β-carboline congeners as potential anticancer agents and DNA topoisomerase II inhibitors.
Sathish M; Kavitha B; Nayak VL; Tangella Y; Ajitha A; Nekkanti S; Alarifi A; Shankaraiah N; Nagesh N; Kamal A
Eur J Med Chem; 2018 Jan; 144():557-571. PubMed ID: 29289881
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel potent cytotoxicy podophyllotoxin-naphthoquinone compounds via microwave-assited multicomponent domino reactions.
Nguyen Thi QG; Le-Nhat-Thuy G; Dang Thi TA; Hoang Thi P; Nguyen Tuan A; Nguyen Thi TH; Nguyen TT; Nguyen Ha T; Hoang Mai H; Nguyen TV
Bioorg Med Chem Lett; 2021 Apr; 37():127841. PubMed ID: 33556568
[TBL] [Abstract][Full Text] [Related]
17. Tubulin inhibitors: Discovery of a new scaffold targeting extra-binding residues within the colchicine site through anchoring substituents properly adapted to their pocket by a semi-flexible linker.
Maklad RM; AbdelHafez EMN; Abdelhamid D; Aly OM
Bioorg Chem; 2020 Jun; 99():103767. PubMed ID: 32325332
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and cytotoxic activity on human cancer cells of carbamate derivatives of 4β-(1,2,3-triazol-1-yl)podophyllotoxin.
Liu JF; Sang CY; Xu XH; Zhang LL; Yang X; Hui L; Zhang JB; Chen SW
Eur J Med Chem; 2013 Jun; 64():621-8. PubMed ID: 23711769
[TBL] [Abstract][Full Text] [Related]
19. Regioselective synthesis and in vitro anticancer activity of 4-aza-podophyllotoxin derivatives catalyzed by L-proline.
Shi C; Wang J; Chen H; Shi D
J Comb Chem; 2010 Jul; 12(4):430-4. PubMed ID: 20503973
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anticancer activity of dimeric podophyllotoxin derivatives.
Zi CT; Yang L; Xu FQ; Dong FW; Yang D; Li Y; Ding ZT; Zhou J; Jiang ZH; Hu JM
Drug Des Devel Ther; 2018; 12():3393-3406. PubMed ID: 30349193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]